Disease-specific overall survival in endometrioid ovarian

Ovarian Cancer (Including the Fallopian Tube)

Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study, Journal of Ovarian Research

Frontiers A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment - Gynecologic Oncology

Disease-specific overall survival in endometrioid ovarian carcinoma

PAOLA-1 Phase 3 Trial – Efficacy of LYNPARZA® (olaparib) + Bevacizumab for Advanced Ovarian Cancer

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - European Journal of

Current Oncology, Free Full-Text

Our goal is always the complete removal of the disease